Allogeneic tonsillar mesenchymal stem cell-derived schwann cell like cells(Cellatoz Therapeutics)

N/A

Report date: 2023/07/19 20:00:33

Base Information

Drug NameAllogeneic tonsillar mesenchymal stem cell-derived schwann cell like cells(Cellatoz Therapeutics)
Drug Alias NameCLZ-2002
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellatoz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellatoz Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A